Genery Wealth Management

Inotek Pharmaceuticals is a privately held biotechnology company based in Lexington, MA, specializing in the discovery and development of innovative treatments for serious ocular diseases. With a robust pipeline focusing on conditions such as glaucoma and age-related macular degeneration, the company employs a scientifically rigorous approach to advance its lead drug candidate, trabodenoson INO-8875, which effectively addresses elevated intraocular pressure. The firm is supported by an experienced management team with a proven track record of successful New Drug Applications (NDAs), aiming to bring its clinical programs to commercialization. In addition to its advanced drug development platform, Inotek offers a range of effective, over-the-counter eye drops for glaucoma, ensuring high-quality products through collaboration with official suppliers and manufacturers. Generated from the website

Parthenon Group was founded in 1991 as a boutique strategic advisory firm. The company offers strategic counsel for a wide range of business issues, including corporate and business unit strategy, profit improvement, mergers and acquisitions, private equity, and innovation and growth. It specializes in consumer products and retail, diversified manufacturing, education, financial services, health care, technology software, and publishing and information. Its clients include Global 1000 companies, private equity firms, and high and emerging growth companies. The company also organizes various community outreach programs in partnership with charities that include The Women s Union, Massachusetts Society for the Prevention of Cruelty to Children, New American Schools, the Wang Center and Boston Symphony Orchestra. Parthenon Group has offices in Boston, San Francisco and London.

Heritage Partners is one of the leading private investment firm specializing in the acquisition and equity-based recapitalization of private, family owned businesses. Since 1987, the Partners have assembled a diversified portfolio of nearly 50 investments with revenues in the billions of dollars. Heritage Partners portfolio is divided into three funds, the Heritage Fund I, Heritage Fund II and Heritage Fund III. The firm's fundamental objective is to invest preferred and common stock, on a minority or majority basis, in mature, successful companies with revenues of $50 to $500 million. Industries of particular interest include healthcare, consumer products, food and beverage, distribution, light manufacturing and media. Heritage Partners is headquartered in Boston.